Our Mission and Values
Board
Leadership Team
Scientific Advisory
Corporate Governance
Intellectual Property
Pipeline
CVac™
Vaccines Program
R&D
Ovarian Cancer
About CVac™
Treatment
Clinical Trials
Clinical Trials
CVac™
CAN-003
CANVAS
FAQ
Useful Links
Contact Us
Company Profile
Analyst Reports
Presentations
Company Calendar
Finance Reports
Investor Updates
Mailing List & IR Contact
Webcasts
Announcements
Announcements
Archive
Announcements
19 June 2013
CVac CAN-003 Trial Selected For Oral Presentation At The European Cancer Congress
>>
13 June 2013
Prima BioMed Ltd - Completion of Entitlement Offer
>>
13 June 2013
Investor Update Edition 10
>>
Privacy Policy
© 2013 PRIMA BIOMED LTD. All Rights Reserved.
Home
Site Map
Contact Us
Search